Cholangiocarcinoma, Gallbladder, Gastrointestinal
A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
Eligible for screening study DCP 001
Effective, March 5th, 2020, study S1815 will be temporarily closed to accrual of new patients. Accrual will re-open after the revision for the accrual goal increase is approved and distributed.